Patent · US Expired

Use of interferon (IFN)-&agr;8 and -&agr;14 as vaccine adjuvants

US6436391B1 · kind B1 · utility

14Cited by

3References

10Claims

0Family size

Assignee

IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE · GB

Inventors

Graham Foster · London, GB
Howard Thomas · London, GB

Key dates

Filing date	Jan 31, 1997
Grant date	Aug 20, 2002
Priority date	—
Expiry date	Jan 31, 2017

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/55522
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The use of IFN-&agr; subtypes as vaccine adjuvants is disclosed, together with vaccine compositions comprising them. Methods of vaccinating a subject comprising co-administration of IFN-&agr; subtypes are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.